Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
absence, acknowledged, AG, agonist, antitrust, Apexigen, APXiMAB, Ascent, assuming, coinsurance, complementary, consummate, consummated, consummation, customary, displayed, Dupont, ESBATech, expansion, fatal, formulating, indemnification, inflationary, injunction, invited, IRA, Jakob, magnitude, mailing, melanoma, nivolumab, ourself, par, penalize, plaintiff, pose, printing, randomized, rapid, redemption, releasing, restraint, round, shelf, sotiga, sotigalimab, stable, stream, symptomatic, timeframe, transient, vacancy
Removed:
avoid, bank, contact, contractor, desire, discontinue, distancing, emergency, Feingold, geographic, globally, home, important, inspectional, insured, intention, interactive, IP, Jay, mission, outbreak, pandemic, postpone, postponed, prioritization, prioritized, quarantine, reducing, remote, resume, resumption, retaining, school, shelter, spread, teamwork, temporarily, temporary, transit, translational, withdrawing, Wuhan
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view